
WHEN it comes to prescribing antibiotics, doctors are in a jam. Giving them too often risks perpetuating the development of resistance to these drugs in bacteria. That is a serious threat to society. But withholding them is also risky. If the decision is wrong, a patient could develop a life-threatening infection.
Even if the doctor is right, this decision often upsets people. I have heard stories of medics being threatened with everything from bad online reviews to physical violence unless they dish the pills.
One of the most dangerous areas of medicine in this regard is urinary tract infections. Many fit and healthy people recover from UTIs without antibiotics. But if drugs are needed, they must be administered quickly, or sepsis might set in. That is why doctors often err on the side of caution and give antibiotics for UTIs before they are sure drugs are needed.
Advertisement
Previous estimates from the US and Australia suggested that about 30 per cent of antibiotic prescriptions given out for UTIs in hospitals and outpatient settings are inappropriate. Now research presented at a conference by Laura Shallcross of University College London suggests the true figure is much higher: between 60 and 70 per cent. This is based on real test results from patients entering an emergency department in a UK hospital, so there is reason to think the shocking figure is accurate.
How do we fix this? The charity I lead, , aims to help fund the development of one new antibiotic treatment and have it on the market by the early 2020s. But this is a tall order. The pharmaceutical industry isn’t putting enough resources into developing new antibiotics. There isn’t enough profit in them because they are only used for short periods. Governments are also partly to blame. Most haven’t put in place financial incentives to encourage more research by pharmaceutical firms.
But rather than focusing on who is to blame, we must work together to solve the problem. For example, we should continue doctors’ education around antibiotic prescriptions. And we could support them in the face of public pressure. Greater public awareness, perhaps delivered by campaigns such as the National Health Service’s Keep Antibiotics Working, would help.
One thing could help far more quickly. Doctors culture bacterial samples from people to identify infections. This method is cheap, but unreliable. What we need are tests that can immediately diagnose the type, severity and antibiotic sensitivity of an infection. Without that, doctors are working in the dark.
Such tests are becoming available, but they are still at the experimental stage. We must put a rocket under their development and light the fuse now.